Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

L-threo-3,4-dihydroxyphenylserine

EU orphan designation number: EU/3/07/466   
Active ingredient: L-threo-3,4-dihydroxyphenylserine
Indication: Treatment of orthostatic hypotension in patients with multiple system atrophy
Sponsor: H. Lundbeck A/S
Ottiliavej 9, 2500 Valby, Danmark

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
6/08/2007 Orphan designation EMEA/OD/025/07 (2007)3818 of 2/08/2007
11/12/2007 Change of name and/or address of sponsor
1/04/2009 Transfer of orphan designation EMEA/OD/025/07/T/01 (2009)2488 of 27/03/2009
9/11/2010 Change of name and/or address of sponsor EMA/581017/2010
11/03/2011 Transfer of orphan designation EMEA/OD/025/07/T/02 (2011)1684 of 9/03/2011
8/12/2015 Transfer of orphan designation EMA/OD/025/07/T/03 (2015)8954 of 4/12/2015